Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
301
datasets available to search
ShareScore release 0.9.0
Dataset results
301 results for “sitagliptin”
Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction
ClinicalTrials.gov study NCT00650143. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment
ClinicalTrials.gov study NCT01100125. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)
ClinicalTrials.gov study NCT05579119. IPD Sharing: NO. Countries: 1. Publications: 9.
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise
ClinicalTrials.gov study NCT02226003. IPD Sharing: YES. Countries: 0. Publications: 7.
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
ClinicalTrials.gov study NCT00701090. IPD Sharing: YES. Countries: 0. Publications: 2.
The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
ClinicalTrials.gov study NCT04365517. IPD Sharing: NO. Countries: 1. Publications: 12.
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)
ClinicalTrials.gov study NCT02036515. IPD Sharing: YES. Countries: 0. Publications: 8.
Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation
ClinicalTrials.gov study NCT05042505. IPD Sharing: YES. Countries: 1. Publications: 10.
Sitagliptin and Brown Adipose Tissue
ClinicalTrials.gov study NCT02294084. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
ClinicalTrials.gov study NCT02318693. IPD Sharing: YES. Countries: 0. Publications: 1.
Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00337610. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes
ClinicalTrials.gov study NCT04298684. IPD Sharing: NO. Countries: 3. Publications: 24.
Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)
ClinicalTrials.gov study NCT02564211. IPD Sharing: YES. Countries: 0. Publications: 1.
Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)
ClinicalTrials.gov study NCT02577016. IPD Sharing: YES. Countries: 0. Publications: 1.
Effects of Sitagliptin in Relatives of T1D Patients
ClinicalTrials.gov study NCT05219409. IPD Sharing: NO. Countries: 1. Publications: 16.
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
ClinicalTrials.gov study NCT00509262. IPD Sharing: YES. Countries: 0. Publications: 1.
Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)
ClinicalTrials.gov study NCT00758069. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
ClinicalTrials.gov study NCT01590797. IPD Sharing: YES. Countries: 0. Publications: 1.
Sitagliptin in Renal Transplant Recipients
ClinicalTrials.gov study NCT00740363. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin
ClinicalTrials.gov study NCT01703637. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.